TP53 and undifferentiated carcinoma: In those reports, patients with anaplastic carcinomas were thought to have DNA damage induced by 131I therapy and the combination of p53, a representative tumor suppressor gene, mutations, and DNA damage induced by 131I therapy is reported to lead to anaplastic transformation [25].